John D Quisel Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for John D Quisel.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of John D Quisel. John D Quisel is EVP, CBO and Secretary in ACCELERON PHARMA INC ($XLRN) and EVP, Chief Business Officer in ACCELERON PHARMA INC ($XLRN) and SVP Gen. Counsel & Secretary in ACCELERON PHARMA INC ($XLRN) and SVP, Bus. Dev., GC & Secretary in ACCELERON PHARMA INC ($XLRN) and SVP, Corp. Dev., GC & Sec. in ACCELERON PHARMA INC ($XLRN) and VP General Counsel & Secretary in ACCELERON PHARMA INC ($XLRN).

Latest Insider Trading Transactions of John D Quisel

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Page: 1 2 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jan 03 2020	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, Chief Business ...	Sell	S	52.52	4,242	222,790	53,316	57.6 K to 53.3 K (-7.37 %)
Jan 03 2020	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, Chief Business ...	Sell	S	52.51	1,600	84,016	57,558	59.2 K to 57.6 K (-2.70 %)
Jan 03 2020	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, Chief Business ...	Sell	S	52.52	4,242	222,790	53,316	57.6 K to 53.3 K (-7.37 %)
Jan 03 2020	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, Chief Business ...	Sell	S	52.51	1,600	84,016	57,558	59.2 K to 57.6 K (-2.70 %)
Sep 10 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, Chief Business ...	Sell	S	45.23	3,584	162,104	59,158	62.7 K to 59.2 K (-5.71 %)
Sep 10 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, Chief Business ...	Sell	S	45.23	3,584	162,104	59,158	62.7 K to 59.2 K (-5.71 %)
Jul 11 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, Chief Business ...	Option Exercise	M	7.12	1,562	11,121	0
Jul 11 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, Chief Business ...	Option Exercise	M	5.28	2,346	12,387	0
Jul 11 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, Chief Business ...	Option Exercise	M	3.88	5,000	19,400	0
Jul 11 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, Chief Business ...	Buy	M	7.12	1,562	11,121	62,742	61.2 K to 62.7 K (+2.55 %)
Jul 11 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, Chief Business ...	Buy	M	5.28	2,346	12,387	61,180	58.8 K to 61.2 K (+3.99 %)
Jul 11 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, Chief Business ...	Buy	M	3.88	5,000	19,400	58,834	53.8 K to 58.8 K (+9.29 %)
Apr 11 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, CBO and Secret ...	Sell	S	44.24	70	3,097	53,834	53.9 K to 53.8 K (-0.13 %)
Apr 11 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, CBO and Secret ...	Sell	S	45.46	100	4,546	53,904	54 K to 53.9 K (-0.19 %)
Apr 11 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, CBO and Secret ...	Sell	S	44.62	3,452	154,028	54,004	57.5 K to 54 K (-6.01 %)
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, CBO and Secret ...	Option Exercise	A	41.64	28,500	1,186,740	28,500
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, CBO and Secret ...	Grant	A	0.00	4,800	0	57,456	52.7 K to 57.5 K (+9.12 %)
Jan 04 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, CBO and Secret ...	Sell	S	43.92	475	20,862	52,656	53.1 K to 52.7 K (-0.89 %)
Jan 04 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, CBO and Secret ...	Sell	S	43.10	2,558	110,250	53,131	55.7 K to 53.1 K (-4.59 %)
Jan 04 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, CBO and Secret ...	Sell	S	42.31	1,300	55,003	55,689	57 K to 55.7 K (-2.28 %)
Jan 04 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, CBO and Secret ...	Sell	S	43.26	300	12,978	56,989	57.3 K to 57 K (-0.52 %)
Jan 04 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, CBO and Secret ...	Sell	S	42.32	1,309	55,397	57,289	58.6 K to 57.3 K (-2.23 %)
Apr 04 2018	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Corp. Dev., GC ...	Sell	S	39.16	100	3,916	56,598	56.7 K to 56.6 K (-0.18 %)
Apr 04 2018	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Corp. Dev., GC ...	Sell	S	38.33	1,104	42,316	56,698	57.8 K to 56.7 K (-1.91 %)
Mar 05 2018	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Corp. Dev., GC ...	Option Exercise	A	40.61	28,950	1,175,660	28,950
Mar 05 2018	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Corp. Dev., GC ...	Grant	A	0.00	4,825	0	57,802	53 K to 57.8 K (+9.11 %)
Jan 04 2018	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Corp. Dev., GC ...	Sell	S	42.42	4,333	183,806	52,977	57.3 K to 53 K (-7.56 %)
Sep 14 2017	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Corp. Dev., GC ...	Sell	S	38.03	8	304	57,310	57.3 K to 57.3 K (-0.01 %)
Sep 14 2017	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Corp. Dev., GC ...	Sell	S	39.37	600	23,622	57,318	57.9 K to 57.3 K (-1.04 %)
Sep 14 2017	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Corp. Dev., GC ...	Sell	S	38.29	4,505	172,496	57,918	62.4 K to 57.9 K (-7.22 %)
Mar 14 2017	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Bus. Dev., GC ...	Option Exercise	A	30.17	46,300	1,396,871	46,300
Mar 14 2017	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Bus. Dev., GC ...	Grant	A	0.00	7,900	0	62,423	54.5 K to 62.4 K (+14.49 %)
Jan 06 2017	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Bus. Dev., GC ...	Sell	S	27.56	1,400	38,584	54,523	55.9 K to 54.5 K (-2.50 %)
Jan 06 2017	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Bus. Dev., GC ...	Sell	S	26.43	300	7,929	55,923	56.2 K to 55.9 K (-0.53 %)
Sep 23 2016	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Bus. Dev., GC ...	Option Exercise	M	3.88	11,500	44,620	5,000
Sep 23 2016	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Bus. Dev., GC ...	Option Exercise	M	24.11	13,671	329,608	15,329
Sep 23 2016	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Bus. Dev., GC ...	Option Exercise	M	7.12	781	5,561	1,562
Sep 23 2016	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Bus. Dev., GC ...	Sell	S	38.05	45,952	1,748,474	56,223	102.2 K to 56.2 K (-44.97 %)
Sep 23 2016	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Bus. Dev., GC ...	Buy	M	3.88	11,500	44,620	102,175	90.7 K to 102.2 K (+12.68 %)
Sep 23 2016	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Bus. Dev., GC ...	Buy	M	24.11	13,671	329,608	90,675	77 K to 90.7 K (+17.75 %)
Sep 23 2016	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Bus. Dev., GC ...	Buy	M	7.12	781	5,561	77,004	76.2 K to 77 K (+1.02 %)
Sep 13 2016	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Bus. Dev., GC ...	Option Exercise	M	7.12	4,688	33,379	2,343
Sep 13 2016	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Bus. Dev., GC ...	Option Exercise	M	5.28	6,250	33,000	0
Sep 13 2016	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Bus. Dev., GC ...	Option Exercise	M	3.88	5,500	21,340	16,500
Sep 13 2016	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Bus. Dev., GC ...	Sell	S	32.14	21,438	689,017	76,223	97.7 K to 76.2 K (-21.95 %)
Sep 13 2016	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Bus. Dev., GC ...	Buy	M	7.12	4,688	33,379	97,661	93 K to 97.7 K (+5.04 %)
Sep 13 2016	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Bus. Dev., GC ...	Buy	M	5.28	6,250	33,000	92,973	86.7 K to 93 K (+7.21 %)
Sep 13 2016	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP, Bus. Dev., GC ...	Buy	M	3.88	5,500	21,340	86,723	81.2 K to 86.7 K (+6.77 %)
Mar 07 2016	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	A	27.97	30,800	861,476	30,800
Mar 07 2016	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Grant	A	0.00	5,100	0	81,223	76.1 K to 81.2 K (+6.70 %)
Sep 16 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	3.88	5,500	21,340	22,000
Sep 16 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	34.17	1,400	47,838	76,123	77.5 K to 76.1 K (-1.81 %)
Sep 16 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	33.07	4,100	135,587	77,523	81.6 K to 77.5 K (-5.02 %)
Sep 16 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	3.88	5,500	21,340	81,623	76.1 K to 81.6 K (+7.23 %)
Sep 11 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Grant	A	0.00	40,000	0	76,123	36.1 K to 76.1 K (+110.73 %)
Aug 17 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	3.88	1,039	4,031	27,500
Aug 17 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	5.88	4,461	26,231	0
Aug 17 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	31.74	2,200	69,828	36,123	38.3 K to 36.1 K (-5.74 %)
Aug 17 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	30.22	3,300	99,726	38,323	41.6 K to 38.3 K (-7.93 %)
Aug 17 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	3.88	1,039	4,031	41,623	40.6 K to 41.6 K (+2.56 %)
Aug 17 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	5.88	4,461	26,231	40,584	36.1 K to 40.6 K (+12.35 %)
Aug 03 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	5.28	5,895	31,126	6,250
Aug 03 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	5.28	7,527	39,743	2,346
Aug 03 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	5.28	5,895	31,126	36,123	30.2 K to 36.1 K (+19.50 %)
Aug 03 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	5.28	7,527	39,743	30,228	22.7 K to 30.2 K (+33.16 %)
Jul 16 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	5.88	5,500	32,340	4,461
Jul 16 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	30.00	5,500	165,000	22,701	28.2 K to 22.7 K (-19.50 %)
Jul 16 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	5.88	5,500	32,340	28,201	22.7 K to 28.2 K (+24.23 %)
Jun 18 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	3.88	7,701	29,880	28,539
Jun 18 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	3.88	7,701	29,880	22,701	15 K to 22.7 K (+51.34 %)
Jun 16 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	5.88	5,500	32,340	9,961
Jun 16 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	31.13	5,500	171,215	15,000	20.5 K to 15 K (-26.83 %)
Jun 16 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	5.88	5,500	32,340	20,500	15 K to 20.5 K (+36.67 %)
May 18 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	5.88	5,500	32,340	15,461
May 18 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	31.81	3,900	124,059	15,000	18.9 K to 15 K (-20.63 %)
May 18 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	31.06	1,600	49,696	18,900	20.5 K to 18.9 K (-7.80 %)
May 18 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	5.88	5,500	32,340	20,500	15 K to 20.5 K (+36.67 %)
Mar 17 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	5.88	4,039	23,749	20,961
Mar 17 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	5.88	1,461	8,591	0
Mar 17 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	5.08	4,000	20,320	0
Mar 17 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	41.20	220	9,064	15,000	15.2 K to 15 K (-1.45 %)
Mar 17 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	40.67	5,280	214,738	15,220	20.5 K to 15.2 K (-25.76 %)
Mar 17 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	5.88	4,039	23,749	20,500	16.5 K to 20.5 K (+24.54 %)
Mar 17 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	5.88	1,461	8,591	16,461	15 K to 16.5 K (+9.74 %)
Mar 17 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	42.05	800	33,640	15,000	15.8 K to 15 K (-5.06 %)
Mar 17 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	41.28	3,200	132,096	15,800	19 K to 15.8 K (-16.84 %)
Mar 17 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	5.08	4,000	20,320	19,000	15 K to 19 K (+26.67 %)
Mar 06 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	5.88	5,500	32,340	1,461
Mar 06 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	5.08	2,000	10,160	4,000
Mar 06 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	1.80	2,000	3,600	0
Mar 06 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	42.06	101	4,248	15,000	15.1 K to 15 K (-0.67 %)
Mar 06 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	41.77	1,066	44,527	15,101	16.2 K to 15.1 K (-6.59 %)
Mar 06 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	40.34	4,333	174,793	16,167	20.5 K to 16.2 K (-21.14 %)
Mar 06 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	5.88	5,500	32,340	20,500	15 K to 20.5 K (+36.67 %)
Mar 06 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	42.07	1	42	15,000	15 K to 15 K (-0.01 %)
Mar 06 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	41.50	1,300	53,950	15,001	16.3 K to 15 K (-7.97 %)
Mar 06 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	40.65	2,699	109,714	16,301	19 K to 16.3 K (-14.21 %)
Mar 06 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	5.08	2,000	10,160	19,000	17 K to 19 K (+11.76 %)
Mar 06 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	1.80	2,000	3,600	17,000	15 K to 17 K (+13.33 %)
Jan 16 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	5.88	2,438	14,335	6,961
Jan 16 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	5.08	1,500	7,620	6,000
Jan 16 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	5.28	1,562	8,247	12,145
Jan 16 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	1.80	500	900	2,000
Jan 16 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	0.92	3,500	3,220	0
Jan 16 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	40.12	5,500	220,660	15,000	20.5 K to 15 K (-26.83 %)
Jan 16 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	5.88	2,438	14,335	20,500	18.1 K to 20.5 K (+13.50 %)
Jan 16 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	5.08	1,500	7,620	18,062	16.6 K to 18.1 K (+9.06 %)
Jan 16 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	5.28	1,562	8,247	16,562	15 K to 16.6 K (+10.41 %)
Jan 16 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	40.62	500	20,310	15,000	15.5 K to 15 K (-3.23 %)
Jan 16 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	39.85	3,500	139,475	15,500	19 K to 15.5 K (-18.42 %)
Jan 16 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	1.80	500	900	19,000	18.5 K to 19 K (+2.70 %)
Jan 16 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	0.92	3,500	3,220	18,500	15 K to 18.5 K (+23.33 %)
Jan 09 2015	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	A	41.20	41,000	1,689,200	41,000
Dec 19 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	3.88	15,000	58,200	36,240
Dec 19 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	3.88	15,000	58,200	15,000	0 to 15 K
Dec 16 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	0.92	4,000	3,680	3,500
Dec 16 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	41.72	2,500	104,300	0	2.5 K to 0 (-100.00 %)
Dec 16 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	40.72	1,500	61,080	2,500	4 K to 2.5 K (-37.50 %)
Dec 16 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	0.92	4,000	3,680	4,000	0 to 4 K
Nov 18 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	0.92	4,000	3,680	7,500
Nov 18 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	34.72	675	23,436	0	675 to 0 (-100.00 %)
Nov 18 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	33.24	3,325	110,523	675	4 K to 675 (-83.12 %)
Nov 18 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	0.92	4,000	3,680	4,000	0 to 4 K
Nov 14 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	7.12	1,899	13,521	7,031
Nov 14 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	5.88	3,101	18,234	9,399
Nov 14 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	33.60	3,043	102,245	0	3 K to 0 (-100.00 %)
Nov 14 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	32.42	1,957	63,446	3,043	5 K to 3 K (-39.14 %)
Nov 14 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	7.12	1,899	13,521	5,000	3.1 K to 5 K (+61.24 %)
Nov 14 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	5.88	3,101	18,234	3,101	0 to 3.1 K
Oct 16 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	0.92	4,000	3,680	11,500
Oct 16 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	29.02	4,000	116,080	0	4 K to 0 (-100.00 %)
Oct 16 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	0.92	4,000	3,680	4,000	0 to 4 K
Oct 01 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	7.12	3,570	25,418	8,930
Oct 01 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	5.28	3,430	18,110	13,707
Oct 01 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	30.01	7,000	210,070	0	7 K to 0 (-100.00 %)
Oct 01 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	7.12	3,570	25,418	7,000	3.4 K to 7 K (+104.08 %)
Oct 01 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	5.28	3,430	18,110	3,430	0 to 3.4 K
Sep 12 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	0.92	2,000	1,840	15,500
Sep 12 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	25.43	2,000	50,860	0	2 K to 0 (-100.00 %)
Sep 12 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	0.92	2,000	1,840	2,000	0 to 2 K
Aug 15 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	5.28	7,863	41,517	17,137
Aug 15 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	5.28	3,137	16,563	9,873
Aug 15 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	0.92	2,000	1,840	17,500
Aug 15 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	30.02	11,000	330,220	0	11 K to 0 (-100.00 %)
Aug 15 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	5.28	7,863	41,517	11,000	3.1 K to 11 K (+250.65 %)
Aug 15 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	5.28	3,137	16,563	3,137	0 to 3.1 K
Aug 15 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Sell	S	29.79	2,000	59,580	0	2 K to 0 (-100.00 %)
Aug 15 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Buy	M	0.92	2,000	1,840	2,000	0 to 2 K
Jul 16 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	5.28	3,000	15,840	13,010
Jul 16 2014	XLRN	ACCELERON PHARMA I ...	Quisel John D	SVP Gen. Counsel & ...	Option Exercise	M	0.92	2,000	1,840	19,500

Page: 1 2 next >